Axsome Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Axsome Therapeutics, Inc. (AXSM) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.320.390.200.090.180.220.01
Cash & Short-Term Investments0.320.390.200.090.180.220.01
Accounts Receivable0.140.090.040.000.000.000.00
Inventory0.020.020.000.000.000.000.00
Other Current Assets0.010.010.000.000.000.000.00
Total Current Assets0.490.500.250.090.180.220.02
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.000.000.000.000.00
Goodwill0.010.010.010.000.000.000.00
Intangible Assets0.050.050.060.000.000.000.00
Other Non-Current Assets0.020.010.010.000.000.000.00
Total Non-Current Assets0.080.080.090.000.000.000.00
Total Assets0.570.590.330.090.190.220.02
Current Liabilities
Accounts Payable0.070.040.040.010.020.020.01
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.150.090.040.010.010.000.00
Other Current Liabilities0.150.010.010.000.000.000.00
Total Current Liabilities0.230.140.100.020.020.020.01
Non-Current Liabilities
Long-Term Debt0.190.180.090.050.050.020.00
Other Non-Current Liabilities0.090.070.030.000.000.000.00
Total Non-Current Liabilities0.280.260.130.050.050.020.00
Total Liabilities0.510.400.220.070.070.040.01
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.12-0.84-0.60-0.41-0.28-0.18-0.11
Additional Paid-in Capital1.181.030.710.420.390.350.11
Shares Outstanding0.050.050.040.040.000.000.00
Total Stockholders' Equity0.060.190.110.020.110.180.00
Total Liabilities & Equity0.570.590.330.090.190.220.02